Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book
The US Court of Appeals for the Federal Circuit yesterday ordered a halt to the delisting of a key patent for Jazz Pharmaceuticals’ narcolepsy drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
